Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
Clinical trial NCT06482268 · RECRUITING
Trial details
- NCT number
- NCT06482268
- Sponsor
- University of California, San Diego
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2027-12-28
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.